Atlas Trials

Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy

Clinical trial NCT01059461 · COMPLETED

Trial details

NCT number
NCT01059461
Sponsor
Sahar M.A. Hassanein, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hypoxic-Ischemic Encephalopathy
Start date
2011-03-01
Primary completion
2013-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.